Issue |
Section |
Title |
File |
Vol 50, No 9 (2016) |
Article |
Selection of Standardization Parameters and Development of Quality Control Methods for Isoleucyl-Tryptophan Dipeptide Coordination Complex with Iron(II) (Timofer) |
|
Vol 50, No 10 (2017) |
Drugs |
Interchangeability Criteria for Levofloxacin-Based Medicinal Products in the Russian Federation |
|
Vol 50, No 12 (2017) |
Drugs |
Planning Bioequivalence Studies of Drugs with Narrow Therapeutic Indices |
|
Vol 51, No 5 (2017) |
Drugs |
Influence of Human Biorhythms on the Blood Glucose Level and the Efficacy of Hypoglycemic Drugs (Review) |
|
Vol 51, No 6 (2017) |
Article |
Toxic and Immunomodulatory Properties of an Iron(II) Coordination Complex of Isoleucyltryptophan Dipeptide |
|
Vol 51, No 8 (2017) |
Article |
Optimization of Drug Administration Dosage Regimen Considering Chronorhythms and Desynchronosis of Gastrointestinal-Tract Organs |
|
Vol 51, No 8 (2017) |
Article |
Interchangeability Problems of Drugs with Narrow Therapeutic Indices |
|
Vol 51, No 11 (2018) |
Article |
Validation of a Quantitative Determination Method for Ormustine in a Lyophilized Dosage Form |
|
Vol 52, No 2 (2018) |
Article |
Development of a Sample-Preparation Procedure for Quantitative Determination of Lead in Sugars by Inductively Coupled-Plasma—Atomic-Emission Spectrometry (ICP-AES) |
|
Vol 52, No 4 (2018) |
Medicinal Plants |
Plant Juices and Related Medicinal Preparations: Issues of Standardization and Quality Control |
|
Vol 52, No 7 (2018) |
Article |
Synthesis and some Pharmacological Properties of an Immunoactive Lysine-Containing Tetrapeptide |
|
Vol 52, No 8 (2018) |
Structure of Chemical Compounds, Methods of Analysis and Process Control |
Standardization of Drug Substances According to the Purity Section |
|
Vol 52, No 10 (2019) |
Article |
Validation of Methods and Procedures in Pharmacopoeial Monographs in the Framework of a Drug Standardization Program |
|
Vol 52, No 11 (2019) |
Structure of Chemical Compounds, Methods of Analysis and Process Control |
Pharmacopoeial Quality Requirements for Medicinal Products |
|